How does the “Grouchy” gene affect the response to antidepressants?

Selective serotonin reuptake inhibitors (SSRIs) are antidepressants that are commonly used as first-line treatment of depression. Examples include Prozac, Zoloft and Paxil. However, 30-40% of affected people do not appear to benefit as well from these treatments.

The “grouchy” version of the SLC6A4 gene may explain some of this variation, as it is associated with a decreased response to SSRIs.

The molecular target of SSRIs is the 5-HTT serotonin transporter protein. People with the “grouchy” gene produce lower levels of this protein, therefore, they have a lower number of SSRI targets, which affects the efficacy of these commonly prescribed antidepressants.

Alternative antidepressants may be recommended for patients carrying the “grouchy” gene.

DNA Anxiety and Depression 5-HTTLPR Test

Find out whether you carry a genetic variant that disrupts your serotonin levels.

Web apps are available to users who have taken the test.

Get Test

Already took the test? Sign in to access your results.

Log In